In Vitro Equinos
2025 – Current
Our success cases have three standout pillars: technical competence, strategic vision of opportunities for each company, and personalized implementation of actions to address each client’s individual needs.
In Vitro Equinos2025 – Current
Ipanema Life Sciences2025 – Current
Labovet2025 – Current
Instituto LiBio2022 – Current
2014 – Current
2025 – 2026
Agreste Leilões Rurais2025
Grupo Ginseng2024 – 2025
Rede Hospitalar São Francisco2024 – 2025
2024 – 2025
2024
Matrix Saúde2024
2021 – 2024
2023
2019 – 2023
2014 – 2023
CCG Saúde2022
2022
2021
2021
Clinipam2020 – 2021
2019 – 2020
2018 – 2020
2018 – 2020
GreenLine2019
2018 – 2019
2017 – 2019
Fundação Julita2017 – 2018
2013 – 2018
2012 – 2018
Associação Paulista do Ministério Público - APMP2017
Fulpel Group2016 – 2017
A Esportiva2015 – 2017
Grupo Cinex2011 – 2017
Delicatessen2013 – 2016
2014
Meninos do Morumbi2013 – 2014
Facility (Prol)2011 – 2014
BrPec2012 – 2013
Servizi Itália2012 – 2013
2011 – 2013
Farmabase2010 – 2013
2011 – 2012
Agrovia2010 – 2012
2010 – 2012
2010 – 2012
2008 – 2009
Rimac2026 – Current
B4A2024 – Current
Digimed2024 – Current
Núttria2018 – Current
2014 – Current
Milplan Engenharia2013 – Current
Grupo Ginseng2024 – 2026
2020 – 2026
Leve Saúde2024 – 2025
Maiori Casa2024 – 2025
2023 – 2025
2018 – 2025
2020 – 2024
Farmabase2010 – 2023
HFocus2020 – 2022
2010 – 2022
2014 – 2018
L5 Networks on sale of shares to
Volaris2026
Papaki2026
Labovet on sale of shares to 2025
XP Investimentos2025
In Vitro Equinos on sale of shares to
Equine Care Group - ECG2025
Estância Resiliência on sale of shares to
Viv Saúde2025
Elofort on its corporate reorganization 2025
2025
Grupo Ginseng on the acquisition of Grupo Queiroz Dourado, a franchisee of
Grupo Boticário2025
NMC2025
JK Capital on the structured debt financing (CRI) for the
Itapê Shopping2025
Ipanema Life Sciences on debt financing from 2025
Ipanema Life Sciences on debt financing from financial institutions 2025
Grupo Ginseng on the acquisition of Grupo DMMA, a franchisee in Bahia of
Grupo Boticário2024
Matrix on sale of shares to 2024
Grupo Cita on the acquisition of
CliaGEN2024
Trestto2024
2024
Patties on the transaction with
Eatopia2023
OPME.log in the business plan construction and valuation 2023
Vida Bem Vinda on sale of shares to
XP / Fert Group2023
2023
2023
SPS Capital (Vinci Compass) in operational due diligence of 2023
2023
Ziyou in raising funds from 2023
2022
Nobre on sale of shares to
Versania Saúde Brasil2022
2022
HMC Capital on the acquisition of 2022
2022
2022
Grupo Cita on the acquisition of 2022
2022
Via on the acquisition of
CNT2022
GART on sale of shares to
NMC2021
2021
2021
Instituto de Radioterapia Vitória - IRV2021
EVCITI on merger with
IBIS2021
2021
2021
2021
Via on the acquisition of
Celer2021
CCG Saúde2021
Centro Pernambucano de Oncologia2021
2021
Brasilflex on sale of shares to 2021
LifeDay Saúde2021
Lifecenter Hospital2021
Recepta Bio in the business plan construction and valuation 2020
Neon2020
2020
CORP2020
2020
2020
Sensumed2020
São Lucas on sale of shares to 2020
2020
2020
2020
2020
2020
2020
Via on the acquisition of stake in 2020
Hospital do Coração2020
Ecole Serviços Médicos - A.M.R.2020
2020
São Lucas Saúde2020
Medquimheo2019
São José Hospital2019
Ghelfond2019
Instituto de Oncologia Kaplan2019
2019
Mediplan Saúde2019
ICB2019
2019
Iana Alimentos on sale of shares to 2019
GreenLine2019
2018
2018
2018
Cettro on sale of shares to 2018
2018

Almofariz, Rhamus e Sweet Remedy on the merger 2018
2018
2018
2018
2018
Itaú2018
Clínica São Vicente on sale of shares to
Rede D'Or São Luiz2017
2017
Hospital São Bernardo2017
2017
2017
2017
Farmabase on the acquisition of 2017
KY2017
Unimed ABC2016
Stink UK2016
2016
2015
Martins Lococo on sale of shares to
Grupo Atmosfera2015
Servizi Itália2015
Santamália Saúde2015
2015
2015
Cine on debt financing from 2014
Mogivet on sale of shares to 2014
2014
2013
Servizi Itália on the acquisition of
MaxLav2013
Bradesco2013
Servizi Itália2012
Kinea in operational due diligence of
Delfin2012
Rede D'Or São Luiz2012
Abase2010
Farmabase2010
Ability on sale of shares to 2010
B4A2024 – Current
2020 – 2025
2014 – 2023
2016 – 2018